Real-time Stock quotes, portfolio, LIVE TV and more.
May 26, 2011, 06.21 PM IST
Fresenius Kabi Oncology has announced its FY11 results. The company's FY11 consolidated net profit was at Rs 16 crore versus loss of Rs 33 crore.
Its consolidated revenues were up at Rs 526 crore versus Rs 489 crore.
Tags: Fresenius Kabi Oncology
Action in Fresenius Kabi Oncology
May 23 2013, 16:33
- in Asian markets
May 23 2013, 09:33
- in Technicals